These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18568338

  • 1. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
    Feifel D, Melendez G, Murray RJ, Tina Tran DN, Rullan MA, Shilling PD.
    Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
    [Abstract] [Full Text] [Related]

  • 2. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C, Beckett SR, Spicer CH, Ashton D, Langlois X, Bennett GW.
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [Abstract] [Full Text] [Related]

  • 3. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S, Davis C, Jones S, Li M.
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [Abstract] [Full Text] [Related]

  • 4. The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature.
    Feifel D, Goldenberg J, Melendez G, Shilling PD.
    Neuropharmacology; 2010 Jan; 58(1):195-8. PubMed ID: 19596358
    [Abstract] [Full Text] [Related]

  • 5. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
    Holly EN, Ebrecht B, Prus AJ.
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):526-31. PubMed ID: 21277173
    [Abstract] [Full Text] [Related]

  • 6. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
    Shilling PD, Richelson E, Feifel D.
    Behav Brain Res; 2003 Jul 14; 143(1):7-14. PubMed ID: 12842291
    [Abstract] [Full Text] [Related]

  • 7. Activation of neurotensin receptor type 1 attenuates locomotor activity.
    Vadnie CA, Hinton DJ, Choi S, Choi Y, Ruby CL, Oliveros A, Prieto ML, Park JH, Choi DS.
    Neuropharmacology; 2014 Oct 14; 85():482-92. PubMed ID: 24929110
    [Abstract] [Full Text] [Related]

  • 8. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
    Prus AJ, Hillhouse TM, LaCrosse AL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar 03; 49():78-84. PubMed ID: 24275076
    [Abstract] [Full Text] [Related]

  • 9. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P, Rompré PP.
    Psychopharmacology (Berl); 2003 Jul 03; 168(3):253-61. PubMed ID: 12682711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
    Blackburn A, Dewar K, Bauco P, Rompré PP.
    Brain Res; 2004 Feb 20; 998(2):184-93. PubMed ID: 14751589
    [Abstract] [Full Text] [Related]

  • 18. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
    Vadnie CA, Ayers-Ringler J, Oliveros A, Abulseoud OA, Choi S, Hitschfeld MJ, Choi DS.
    Behav Brain Res; 2016 May 15; 305():8-17. PubMed ID: 26909848
    [Abstract] [Full Text] [Related]

  • 19. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ, Schuck CJ, Rusch KR, Carey LM.
    Drug Dev Res; 2014 Mar 15; 75(2):47-58. PubMed ID: 24668440
    [Abstract] [Full Text] [Related]

  • 20. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
    Briody S, Boules M, Oliveros A, Fauq I, Richelson E.
    Behav Brain Res; 2010 Feb 11; 207(1):118-24. PubMed ID: 19800922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.